NASDAQ: RAPP - Rapport Therapeutics, Inc.

半年間の収益性: -50.93%
配当利回り: 0.00%
セクタ: Healthcare

プロモーションスケジュール Rapport Therapeutics, Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について Rapport Therapeutics, Inc.

Rapport Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder.

さらに詳しく
The company also develops RAP-199, a TARPy8 targeted molecule with differentiated chemical and pharmacokinetic properties; and nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and a9a10 nAChR for the treatment of hearing disorders. Rapport Therapeutics, Inc. was incorporated in 2022 and is headquartered in Boston, Massachusetts.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

IPO date 2024-06-07
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.rapportrx.com
Цена ао 9.7
1日あたりの価格変動: +3.61% (9.7)
週ごとの価格変動: +3.4% (9.72)
月ごとの料金変更: -8.97% (11.04)
3ヶ月間の価格変動: -47.19% (19.03)
半年間の価格変動: -50.93% (20.48)
年初からの価格変動: -43.35% (17.74)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0 0
P/BV 12.05 1
P/E 0 0
EV/EBITDA -43.63 0
合計: 0.625

効率

名前 意味 学年
ROA, % -33.3 0
ROE, % -35.09 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.0178 10
合計: 9.8

成長の衝動

名前 意味 学年
収益性 Revenue, % 0 0
収益性 Ebitda, % 702.31 10
収益性 EPS, % 29.66 4
合計: 6.8
さらに詳しく

ETF共有, %年間の利益率, %配当金, %
iShares Neuroscience and Healthcare ETF 0.71137 19.72 0.03
iShares Micro-Cap ETF 0.04983 17.09 1.54048
iShares Russell 2000 Growth ETF 0.00794 38.04 0.6026
0.2624.950.72



スーパーバイザー 役職 支払い 生年
Dr. Steven M. Paul M.D. Founder & Independent Chairman 1951 (74 年)
Mr. Abraham N. Ceesay M.B.A. CEO, President, Treasurer & Director 1978 (47 年)
Dr. Troy A. Ignelzi Chief Financial Officer 1968 (57 年)
Ms. Cheryl Gault Chief Operating Officer 1979 (46 年)
Mr. David Bredt M.D., Ph.D. Founder & Chief Scientific Officer 1965 (60 年)
Ms. Karina Chmielewski Chief Information Officer & Head of Operations
Ms. Julie DiCarlo Head of Communications & Investor Relations
Ms. Kathleen A. Wilkinson Chief People Officer 1972 (53 年)
Dr. Bradley S. Galer M.D. Chief Medical Officer 1962 (63 年)
Mr. Swamy Yeleswaram Ph.D. Chief Development Officer 1963 (62 年)

住所: United States, Boston, 1325 Boylston Street - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.rapportrx.com